JCS Pharmaceuticals
JCS 制药公司
JCS Pharmaceuticals, Inc. 成立的目的是销售药品、营养品、食品补充剂、医疗器械和其他类似产品。 JCSPI 引入菲律宾的第一个产品是 Genacol®，这是一种来自加拿大的食品补充剂，含有 AminoLock® 胶原蛋白，可治疗关节和肌肉疼痛。
- Type
- distributor (our classification of the record, not a statement by the company)
- Role
- Distributor
- Location
- Netherlands
- Website
- https://jcspharmaceuticals.com
- Categories
- 药品制造, 医疗保健用品, 补充剂与健康
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-08 Mail server of the company domain
- debarment-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- domain-registered (green), checked 2026-08-08 Domain registry record
- sanctions-clear (green), checked 2026-08-08 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)